Cargando…

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value

Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussien, Amr Elsayed M., Furth, Christian, Schönberger, Stefan, Hundsdoerfer, Patrick, Steffen, Ingo G., Amthauer, Holger, Müller, Hans-Wilhelm, Hautzel, Hubertus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381259/ https://www.ncbi.nlm.nih.gov/pubmed/25635760 http://dx.doi.org/10.3390/cancers7010287

Ejemplares similares

Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients
por: Furth, Christian, et al.
Publicado: (2013)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations
por: Jensen, Laura J., et al.
Publicado: (2022)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
por: Nikulin, Pavel, et al.
Publicado: (2020)

The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases
por: Rogasch, Julian MM, et al.
Publicado: (2015)

Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
por: Steffen, Ingo G, et al.
Publicado: (2013)

The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction
por: Rogasch, Julian MM, et al.
Publicado: (2014)

FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
por: Beattie, Bradley J., et al.
Publicado: (2022)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
por: Siefert, Jeffrey, et al.
Publicado: (2023)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
por: Rogasch, Julian M., et al.
Publicado: (2020)

Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
por: Hockmann, Jan, et al.
Publicado: (2023)

Relation between nodule size and (18)F-FDG-PET SUV for malignant and benign pulmonary nodules.
por: Khalaf, Majid, et al.
Publicado: (2008)

The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
por: Leijenaar, Ralph T.H., et al.
Publicado: (2015)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
por: Hack, Ruben I., et al.
Publicado: (2021)

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2021)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT
por: Futamura, Manabu, et al.
Publicado: (2015)

ChatGPT: Can You Prepare My Patients for [(18)F]FDG PET/CT and Explain My Reports?
por: Rogasch, Julian M.M., et al.
Publicado: (2023)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

Calculating an estimate of tissue integrated activity in (18)F-FDG PET imaging using one SUV value
por: Laffon, Eric, et al.
Publicado: (2013)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
por: Liao, Xuhe, et al.
Publicado: (2023)

A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [(18)F]FDG-PET/CT parameters
por: Rogasch, Julian M. M., et al.
Publicado: (2023)

Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification
por: Cistaro, Angelina, et al.
Publicado: (2013)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sn97hngvdoj59r11b2nosq6le3